Keng Ye, Zunjin Ke, Weima Gesang, Ke Liang, Melika Malek
{"title":"A review of exercise-induced epigenetic modifications in prostate tissue: implications for gene expression and tumor progression in prostate cancer.","authors":"Keng Ye, Zunjin Ke, Weima Gesang, Ke Liang, Melika Malek","doi":"10.1186/s12935-025-03950-4","DOIUrl":null,"url":null,"abstract":"<p><p>Physical exercise is associated with a lower incidence and development of prostate cancer (PCa), according to epidemiologic research. In particular, it modifies the levels of endogenous hormones such as insulin, testosterone, and insulin-like growth factor. Moreover, physical exercise of various sorts and durations may affect the tumor microenvironment differently. There is growing evidence that physical exercise is associated with epigenetic alterations in prostate tissue, although its consequences on the prostate are yet unknown. It is well recognized that epigenetic changes, including DNA methylation and histone modifications, interfere with important biological functions in malignancies, including tumor development, tissue invasion, and metastasis, and they also increase the likelihood of genetic abnormalities. Notably, exercise has been shown to have anticancer, DNA methylation, histone, microRNA, lncRNA, and apoptosis-inducing properties. Exercise capacity to alter biomarkers of DNA methylation, histone changes, miRNA, lncRNA, and apoptotic induction makes predictive diagnostics possible, enabling patient stratification and early identification of at-risk patients. Thus, this review summarizes research on the molecular processes and therapeutic applications of exercise in prostate tissue, particularly in the context of prostate cancer.</p>","PeriodicalId":9385,"journal":{"name":"Cancer Cell International","volume":"25 1","pages":"327"},"PeriodicalIF":6.0000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12495689/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Cell International","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12935-025-03950-4","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Physical exercise is associated with a lower incidence and development of prostate cancer (PCa), according to epidemiologic research. In particular, it modifies the levels of endogenous hormones such as insulin, testosterone, and insulin-like growth factor. Moreover, physical exercise of various sorts and durations may affect the tumor microenvironment differently. There is growing evidence that physical exercise is associated with epigenetic alterations in prostate tissue, although its consequences on the prostate are yet unknown. It is well recognized that epigenetic changes, including DNA methylation and histone modifications, interfere with important biological functions in malignancies, including tumor development, tissue invasion, and metastasis, and they also increase the likelihood of genetic abnormalities. Notably, exercise has been shown to have anticancer, DNA methylation, histone, microRNA, lncRNA, and apoptosis-inducing properties. Exercise capacity to alter biomarkers of DNA methylation, histone changes, miRNA, lncRNA, and apoptotic induction makes predictive diagnostics possible, enabling patient stratification and early identification of at-risk patients. Thus, this review summarizes research on the molecular processes and therapeutic applications of exercise in prostate tissue, particularly in the context of prostate cancer.
期刊介绍:
Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques.
The journal focuses on novel cancer studies reporting data from biological experiments performed on cells grown in vitro, in two- or three-dimensional systems, and/or in vivo (animal experiments). These types of experiments have provided crucial data in many fields, from cell proliferation and transformation, to epithelial-mesenchymal interaction, to apoptosis, and host immune response to tumors.
Cancer Cell International also considers articles that focus on novel technologies or novel pathways in molecular analysis and on epidemiological studies that may affect patient care, as well as articles reporting translational cancer research studies where in vitro discoveries are bridged to the clinic. As such, the journal is interested in laboratory and animal studies reporting on novel biomarkers of tumor progression and response to therapy and on their applicability to human cancers.